Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 9 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Katodritou, Eirini  [Clear All Filters]
Journal Article
Apalla, Z., Bobos M., Lallas A., Lazaridou E., & Katodritou E. (2020).  Bortezomib induced purpuric rash.. Dermatol Ther. 33(4), e13651.
Kastritis, E., Gavriatopoulou M., Kyrtsonis M-C., Roussou M., Hadjiharissi E., Symeonidis A., et al. (2015).  Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.. Blood. 126(11), 1392-4.
Katodritou, E., Speletas M., Zervas K., Kapetanos D., Georgiou E., Christoforidou A., et al. (2006).  Evaluation of hypochromic erythrocytes in combination with sTfR-F index for predicting response to r-HuEPO in anemic patients with multiple myeloma.. Lab Hematol. 12(1), 47-54.
Katodritou, E., Terpos E., Kastritis E., Delimpasis S., Symeonidis A. S., Repousis P., et al. (2015).  Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.. Ann Hematol. 94(12), 2033-42.
Vahtsevanos, K., Kyrgidis A., Verrou E., Katodritou E., Triaridis S., Andreadis C. G., et al. (2009).  Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.. J Clin Oncol. 27(32), 5356-62.
Avramouli, A., Tsochas S., Mandala E., Katodritou E., Ioannou M., Ritis K., et al. (2009).  Methylation status of RASSF1A in patients with chronic myeloid leukemia.. Leuk Res. 33(8), 1130-2.
Apalla, Z., Kirtsios T-N., Katodritou E., Lallas A., Konstantinou D., & Karamitsos T. (2019).  Pinch purpura unmasking systemic amyloidosis.. Int J Dermatol. 58(10), e195-e196.
Katodritou, E., Kyrtsonis M-C., Delimpasi S., Kyriakou D., Symeonidis A., Spanoudakis E., et al. (2018).  Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival.. Ann Hematol. 97(9), 1671-1682.
Katodritou, E., Terpos E., Delimpasi S., Kotsopoulou M., Michalis E., Vadikolia C., et al. (2018).  Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.. Blood Cancer J. 8(3), 31.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές